GSK 961081
Batefenterol
CAS: 743461-65-6
Molecular Formula: C40H42ClN5O7
GSK 961081 - Names and Identifiers
| Name | Batefenterol |
| Synonyms | TD5959 TD-5959 TD 5959 GSK961081 GSK 961081 GSK-961081 Batefenterol BATEFENTEROL Batefenterol(GSK961081) GSK-961081,Batefenterol (R)-1-(3-((2-Chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino)methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[3-[[2-chloro-4-[[[(2R)-2-(1,2-dihydro-8-hydroxy-2-oxo-5-quinolinyl)-2-hydroxyethyl]amino]methyl]-5-methoxyphenyl]amino]-3-oxopropyl]-4-piperidinyl ester |
| CAS | 743461-65-6 |
GSK 961081 - Physico-chemical Properties
| Molecular Formula | C40H42ClN5O7 |
| Molar Mass | 740.24 |
| Density | 1.41±0.1 g/cm3(Predicted) |
| Boling Point | 948.3±65.0 °C(Predicted) |
| Solubility | DMSO: 10 mM |
| pKa | 8.89±0.20(Predicted) |
| Storage Condition | -20℃ |
| Use | Batefenterol (GSK961081;TD-5959) is a new muscarinic receptor antagonist and β2-adrenoceptor agonist. It has high affinity for hM2,hM3 and β2-adrenoceptors with Ki values of 1.4, 1.3 and 3.7nM respectively. |
GSK 961081 - Preparation solution concentration reference
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.351 ml | 6.755 ml | 13.509 ml |
| 5 mM | 0.27 ml | 1.351 ml | 2.702 ml |
| 10 mM | 0.135 ml | 0.675 ml | 1.351 ml |
| 5 mM | 0.027 ml | 0.135 ml | 0.27 ml |
Last Update：2024-01-02 23:10:35
Supplier List
Spot supply
Product Name: Batefenterol Visit Supplier Webpage Request for quotationCAS: 743461-65-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Spot supply
Product Name: Batefenterol Visit Supplier Webpage Request for quotationCAS: 743461-65-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History